Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβA. Mishra, Charlotta Dabrosin|Oncotarget|2016Cited by 48
Fulvestrant-Mediated Attenuation of the Innate Immune Response Decreases ER+ Breast Cancer Growth <i>In Vivo</i> More Effectively than TamoxifenAnnelie Abrahamsson, Charlotta Dabrosin|Cancer Research|2020Cited by 21